Holen Sie sich die Stockscreener-App
41.03
1.61%
0.65
Vorhandelsmarkt:
41.03
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
Momentum Shift: Why is Qiagen NV stock going up2026 Pullback Review & Community Trade Idea Sharing Platform - baoquankhu1.vn
Qiagen (QGEN) upgraded to buy by Deutsche Bank after 30% decline - MSN
Qiagen N.V. (NYSE:QGEN) Given Average Rating of "Hold" by Brokerages - MarketBeat
Qiagen N.V. (QGEN) Rolls Out QIAstat-Dx Rise, Expands U.S. Testing Access - MSN
Qiagen N.V. (QIA.DE) stock price, news, quote and history - Yahoo Finance UK
Molecular Diagnostics Market Size is Expected to Reach USD 43.50 Billion by 2035 Owing to the Surging Demand for Accurate and Early Disease Detection Globally | SNS Insider - GlobeNewswire Inc.
Bank of America Discloses 3.01% Voting Stake in Qiagen - TipRanks
Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen (QGEN) Upgraded to Buy by Deutsche Bank After 30% Decline - Insider Monkey
QGEN Technical Analysis & Stock Price Forecast - Intellectia AI
Bruker appoints QIAGEN CEO Thierry Bernard to board of directors By Investing.com - Investing.com Australia
Qiagen N.V. Stock: Leader in Molecular Diagnostics Faces CEO Transition Amid Steady Growth Outlook - AD HOC NEWS
Bruker appoints QIAGEN CEO Thierry Bernard to board of directors - Investing.com
List of 26 Acquisitions by Qiagen (Apr 2026) - Tracxn
Bear Alert: Whats next for Qiagen NV stock2026 Weekly Recap & Risk Managed Investment Strategies - baoquankhu1.vn
Qiagen N.V. Stock: Oversold Opportunity in Sample-to-Insight Leader Amid Biotech Sector Shifts - AD HOC NEWS
Allspring Global Investments Holdings LLC Boosts Position in Qiagen N.V. $QGEN - MarketBeat
QGEN Stock Price, Quote & Chart | QIAGEN N.V. (NYSE:QGEN) - ChartMill
QIAGEN NV Hits New 52-Week Low at USD 38.80 Amid Declining Performance - Markets Mojo
AlphaValue/Baader Europe Upgrades Qiagen to Buy - marketscreener.com
The Bull Case For Qiagen (QGEN) Could Change Following New QuantiFERON-TB Gold Plus EvidenceLearn Why - simplywall.st
Qiagen (QGEN) Valuation Check As New QuantiFERON TB Data Reinforces Leadership In Tuberculosis Detection - Sahm
Qiagen NV at Leerink Global Healthcare Conference Transcript - GuruFocus
Qiagen (NYSE:QGEN) Cut to "Hold" at Wall Street Zen - MarketBeat
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Qiagen N.V. Stock: Steady Position in Molecular Diagnostics Amid Sector Growth Opportunities - AD HOC NEWS
Qiagen (NYSE:QGEN) Sets New 52-Week LowTime to Sell? - MarketBeat
Aug Highlights: Should I set a stop loss on Qiagen NVProfit Target & High Conviction Investment Ideas - baoquankhu1.vn
Qiagen N.V. Stock: A Core Player in Molecular Diagnostics for Long-Term Investor Focus - AD HOC NEWS
QIAGEN NV Hits New 52-Week Low at USD 39.26 Amid Ongoing Decline - Markets Mojo
Qiagen N.V. stock faces pressure amid biotech sector volatility and recent market caution - AD HOC NEWS
Qiagen N.V. stock faces pressure amid biotech sector volatility and recent price dip on Frankfurt ex - AD HOC NEWS
Portfolio Update: How does Qiagen NV score in quality rankings2026 Geopolitical Influence & Verified Short-Term Plans - baoquankhu1.vn
Aug Gainers: Can Qiagen NV ride the EV waveTrade Volume Report & Free Technical Pattern Based Buy Signals - baoquankhu1.vn
Should You Add QIAGEN Stock to Your Portfolio for Now? - MSN
Why is Qiagen (QGEN) down 9.4% since last earnings report? - MSN
AI in Omics Studies Market is Going to Boom | Major Giants QIAGEN, Microsoft, NVIDIA - openPR.com
JPMorgan Chase & Co. Has $33.09 Million Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen N.V. stock faces pressure amid genomics slowdown as DACH investors eye biotech resilience - AD HOC NEWS
Breakout Zone: Is Qiagen NV part of any major index2026 Volume & Daily Growth Stock Investment Tips - baoquankhu1.vn
Tracer Biotechnologies and QIAGEN to advance blood-based MRD testing for solid tumors - MSN
Institution Moves: Is Qiagen NV stock a smart retirement pick2026 Investor Takeaways & Growth Focused Entry Point Reports - baoquankhu1.vn
QIAGEN reports supervisory board member’s restricted stock unit vesting and share settlement - TipRanks
Agilent, Danaher could be potential buyers of Qiagenanalyst - MSN
Fundamentals Check: Does Qiagen NV align with a passive investing strategy2026 Sector Moves & Weekly Chart Analysis and Guides - baoquankhu1.vn
Qiagen N.V. stock rises on strong Q4 earnings and genomics demand surge amid AI biotech push - AD HOC NEWS
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results - pharmiweb.com
Qiagen (NYSE:QGEN) Hits New 12-Month LowShould You Sell? - MarketBeat
PTA-CMS: QIAGEN N.V.: Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView
Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act] - TradingView
Qiagen N : Annual Report for Fiscal Year Ending December 31, 2025 (Form 20-F) - marketscreener.com
Qiagen N.V. stock gains spotlight with new QuantiFERON-TB data amid genomics challenges - AD HOC NEWS
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention - biospace.com
Qiagen N.V. stock faces headwinds from genomics slowdown amid new TB test data - AD HOC NEWS
Deutsche Bank downgrades Qiagen NV (QGEN) - msn.com
QGEN: New Data Highlights Efficacy of QuantiFERON-TB Gold Plus T - GuruFocus
Qiagen announces newly published data supporting efficacy of QuantiFERON - TipRanks
Qiagen N.V. Stock (ISIN: NL0012169213) Faces Headwinds Amid Genomics Slowdown and Strategic Shifts - AD HOC NEWS
0.17%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):